Abstract

Actin dynamics control early T-cell receptor (TCR) signalling during T-cell activation. However, the precise regulation of initial actin rearrangements is not completely understood. Here, we have investigated the regulatory role of the phosphatase Slingshot-1 (SSH1) in this process. Our data show that SSH1 rapidly polarises to nascent cognate synaptic contacts and later relocalises to peripheral F-actin networks organised at the mature immunological synapse. Knockdown of SSH1 expression by CRISPR/Cas9-mediated genome editing or small interfering RNA reveal a regulatory role for SSH1 in CD3ε conformational change, allowing Nck binding and proper downstream signalling and immunological synapse organisation. TCR triggering induces SSH1-mediated activation of actin dynamics through a mechanism mediated by Limk-1 inactivation. These data suggest that during early TCR activation, SSH1 is required for rapid F-actin rearrangements that mediate initial conformational changes of the TCR, integrin organisation and proximal signalling events for proper synapse organisation. Therefore, the SSH1 and Limk-1 axis is a key regulatory element for full T cell activation.

This study identifies a role for the phosphatase Slingshot-1 in controlling LIMK1 and PAK1 signalling to achieve the cytoskeletal rearrangements that facilitate NCK recruitment to the T-cell receptor and downstream signaling.

Details

Title
Human T-cell receptor triggering requires inactivation of Lim kinase-1 by Slingshot-1 phosphatase
Author
Gómez-Morón, Álvaro 1 ; Alegre-Gómez, Sergio 2 ; Ramirez-Muñoz, Rocio 2 ; Hernaiz-Esteban, Alicia 2 ; Carrasco-Padilla, Carlos 2 ; Scagnetti, Camila 3 ; Aguilar-Sopeña, Óscar 2 ; García-Gil, Marta 2 ; Borroto, Aldo 4 ; Torres-Ruiz, Raul 5 ; Rodriguez-Perales, Sandra 6   VIAFID ORCID Logo  ; Sánchez-Madrid, Francisco 7 ; Martín-Cófreces, Noa Beatriz 8   VIAFID ORCID Logo  ; Roda-Navarro, Pedro 2   VIAFID ORCID Logo 

 Universidad Complutense de Madrid, Department of Immunology, Ophthalmology and ENT, School of Medicine, Madrid, Spain (GRID:grid.4795.f) (ISNI:0000 0001 2157 7667); 12 de Octubre Health Research Institute (imas12), Madrid, Spain (GRID:grid.144756.5) (ISNI:0000 0001 1945 5329); UAM, Immunology Service, Instituto de Investigación Sanitaria del Hospital Universitario La Princesa, IIS-Princesa, Madrid, Spain (GRID:grid.5515.4) (ISNI:0000000119578126) 
 Universidad Complutense de Madrid, Department of Immunology, Ophthalmology and ENT, School of Medicine, Madrid, Spain (GRID:grid.4795.f) (ISNI:0000 0001 2157 7667); 12 de Octubre Health Research Institute (imas12), Madrid, Spain (GRID:grid.144756.5) (ISNI:0000 0001 1945 5329) 
 UAM, Immunology Service, Instituto de Investigación Sanitaria del Hospital Universitario La Princesa, IIS-Princesa, Madrid, Spain (GRID:grid.5515.4) (ISNI:0000000119578126); UAM, Videomicroscopy Unit, Instituto de Investigación Sanitaria del Hospital Universitario La Princesa, IIS-Princesa, Madrid, Spain (GRID:grid.5515.4) (ISNI:0000000119578126) 
 Campus de Cantoblanco, Centro de Biología Molecular Severo Ochoa, Madrid, Spain (GRID:grid.465524.4) 
 Centro Nacional de Investigaciones Oncológicas (CNIO), Molecular Cytogenetics and Genome Editing Unit, Human Cancer Genetics Program, Madrid, Spain (GRID:grid.7719.8) (ISNI:0000 0000 8700 1153); Medioambientales y Tecnologicas (CIEMAT); Advanced Therapies Unit, Instituto de Investigacion Sanitaria Fundacion Jiménez Díaz; Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Division of Hematopoietic Innovative Therapies, Biomedical Innovation Unit, Centro de Investigaciones Energéticas, Madrid, Spain (GRID:grid.452372.5) (ISNI:0000 0004 1791 1185); Advanced Therapies Unit, Instituto de Investigación Sanitaria Fundación Jiménez Díaz (IIS-FJD, UAM), Madrid, Spain (GRID:grid.5515.4) (ISNI:0000000119578126) 
 Centro Nacional de Investigaciones Oncológicas (CNIO), Molecular Cytogenetics and Genome Editing Unit, Human Cancer Genetics Program, Madrid, Spain (GRID:grid.7719.8) (ISNI:0000 0000 8700 1153) 
 UAM, Immunology Service, Instituto de Investigación Sanitaria del Hospital Universitario La Princesa, IIS-Princesa, Madrid, Spain (GRID:grid.5515.4) (ISNI:0000000119578126); Fundación Centro Nacional de Investigaciones Cardiovasculares-Carlos III, Area of Vascular Pathophysiology, Laboratory of Intercellular Communication, Madrid, Spain (GRID:grid.467824.b) (ISNI:0000 0001 0125 7682); CIBER de Enfermedades Cardiovasculares (CIBERCV), Madrid, Spain (GRID:grid.510932.c) 
 UAM, Immunology Service, Instituto de Investigación Sanitaria del Hospital Universitario La Princesa, IIS-Princesa, Madrid, Spain (GRID:grid.5515.4) (ISNI:0000000119578126); UAM, Videomicroscopy Unit, Instituto de Investigación Sanitaria del Hospital Universitario La Princesa, IIS-Princesa, Madrid, Spain (GRID:grid.5515.4) (ISNI:0000000119578126); Fundación Centro Nacional de Investigaciones Cardiovasculares-Carlos III, Area of Vascular Pathophysiology, Laboratory of Intercellular Communication, Madrid, Spain (GRID:grid.467824.b) (ISNI:0000 0001 0125 7682); CIBER de Enfermedades Cardiovasculares (CIBERCV), Madrid, Spain (GRID:grid.510932.c) 
Pages
918
Publication year
2024
Publication date
2024
Publisher
Nature Publishing Group
e-ISSN
23993642
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
3086189375
Copyright
© The Author(s) 2024. This work is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.